Global Healthcare Innovation Alliance Accelerator (GHIAA)
@ghiaa.bsky.social
Our Vision: A world in which medical innovations are promptly available to all populations in need.
New on the MAPGuide: Protalix BioTherapeutics & Fiocruz (Brazil) enter a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.
📖 https://ghiaa.org/mapguide-home/search-results/?qs=Protalix+-+Fiocruz%2C+Gaucher+Disease+Therapy+Technology+Transfer+Agreement
📖 https://ghiaa.org/mapguide-home/search-results/?qs=Protalix+-+Fiocruz%2C+Gaucher+Disease+Therapy+Technology+Transfer+Agreement
October 28, 2025 at 3:38 PM
New on the MAPGuide: Protalix BioTherapeutics & Fiocruz (Brazil) enter a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.
📖 https://ghiaa.org/mapguide-home/search-results/?qs=Protalix+-+Fiocruz%2C+Gaucher+Disease+Therapy+Technology+Transfer+Agreement
📖 https://ghiaa.org/mapguide-home/search-results/?qs=Protalix+-+Fiocruz%2C+Gaucher+Disease+Therapy+Technology+Transfer+Agreement
📚 Have you checked out what we read last month?
European Health and Digital Executive Agency (HaDEA) #EU4Health calls on crisis preparedness are open until Dec 4, 2025
Discover more & subscribe → https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
European Health and Digital Executive Agency (HaDEA) #EU4Health calls on crisis preparedness are open until Dec 4, 2025
Discover more & subscribe → https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
October 15, 2025 at 9:45 AM
📚 Have you checked out what we read last month?
European Health and Digital Executive Agency (HaDEA) #EU4Health calls on crisis preparedness are open until Dec 4, 2025
Discover more & subscribe → https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
European Health and Digital Executive Agency (HaDEA) #EU4Health calls on crisis preparedness are open until Dec 4, 2025
Discover more & subscribe → https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
New on the MAPGuide 📖
Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials.
Read more here
🔗 https://ghiaa.org/mapguide-home/search-results/?qs=Tectonic+Therapeutic+License+Agreement
Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials.
Read more here
🔗 https://ghiaa.org/mapguide-home/search-results/?qs=Tectonic+Therapeutic+License+Agreement
October 8, 2025 at 3:28 PM
New on the MAPGuide 📖
Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials.
Read more here
🔗 https://ghiaa.org/mapguide-home/search-results/?qs=Tectonic+Therapeutic+License+Agreement
Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials.
Read more here
🔗 https://ghiaa.org/mapguide-home/search-results/?qs=Tectonic+Therapeutic+License+Agreement
September Newsletter just dropped!
Inside: Julia’s take on global health convenings, new MAPGuide entries, insights from the Vaccine Law Conference + recording, and a warm team welcome.
🔗 https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
#GHIAA
Inside: Julia’s take on global health convenings, new MAPGuide entries, insights from the Vaccine Law Conference + recording, and a warm team welcome.
🔗 https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
#GHIAA
September 30, 2025 at 2:23 PM
September Newsletter just dropped!
Inside: Julia’s take on global health convenings, new MAPGuide entries, insights from the Vaccine Law Conference + recording, and a warm team welcome.
🔗 https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
#GHIAA
Inside: Julia’s take on global health convenings, new MAPGuide entries, insights from the Vaccine Law Conference + recording, and a warm team welcome.
🔗 https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
#GHIAA
In this edition of Policies to Impact, we introduce you to GHIAA board member Magali Poinot and reintroduce our Equitable Access Pyramid!
www.linkedin.com/pulse/polici...
www.linkedin.com/pulse/polici...
March 27, 2025 at 12:59 PM
In this edition of Policies to Impact, we introduce you to GHIAA board member Magali Poinot and reintroduce our Equitable Access Pyramid!
www.linkedin.com/pulse/polici...
www.linkedin.com/pulse/polici...
New on the MAPGuide: IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
Read the agreement here: lnkd.in/e8HUWVNm
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: lnkd.in/e8HUWVNm
Explore the MAPGuide here: lnkd.in/d6ZcxXN
March 27, 2025 at 12:58 PM
New on the MAPGuide: IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
Read the agreement here: lnkd.in/e8HUWVNm
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: lnkd.in/e8HUWVNm
Explore the MAPGuide here: lnkd.in/d6ZcxXN
New on the MAPGuide: Public Health England, Model Fast Track Testing & Evaluation Agreement
Read the agreement here: ow.ly/Vpok50UY6iM
Explore the MAPGuide here: ow.ly/Gm9Q50UY6iL
Read the agreement here: ow.ly/Vpok50UY6iM
Explore the MAPGuide here: ow.ly/Gm9Q50UY6iL
March 21, 2025 at 2:33 PM
New on the MAPGuide: Public Health England, Model Fast Track Testing & Evaluation Agreement
Read the agreement here: ow.ly/Vpok50UY6iM
Explore the MAPGuide here: ow.ly/Gm9Q50UY6iL
Read the agreement here: ow.ly/Vpok50UY6iM
Explore the MAPGuide here: ow.ly/Gm9Q50UY6iL
New on the MAPGuide: PTC Therapeutics - Roche - Spinal Muscular Atrophy Foundation, Spinal Muscular Atrophy License and Collaboration Agreement
Read the agreement here: lnkd.in/esQqfEwc
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: lnkd.in/esQqfEwc
Explore the MAPGuide here: lnkd.in/d6ZcxXN
March 17, 2025 at 12:14 PM
New on the MAPGuide: PTC Therapeutics - Roche - Spinal Muscular Atrophy Foundation, Spinal Muscular Atrophy License and Collaboration Agreement
Read the agreement here: lnkd.in/esQqfEwc
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: lnkd.in/esQqfEwc
Explore the MAPGuide here: lnkd.in/d6ZcxXN
New on the MAPGuide: MPP – Biovac, mRNA Vaccine Technology Transfer Agreement
Read the agreement here: ow.ly/sM5w50UY5we
Explore the MAPGuide here: ow.ly/Grb850UY5wf
Read the agreement here: ow.ly/sM5w50UY5we
Explore the MAPGuide here: ow.ly/Grb850UY5wf
February 26, 2025 at 1:53 PM
New on the MAPGuide: MPP – Biovac, mRNA Vaccine Technology Transfer Agreement
Read the agreement here: ow.ly/sM5w50UY5we
Explore the MAPGuide here: ow.ly/Grb850UY5wf
Read the agreement here: ow.ly/sM5w50UY5we
Explore the MAPGuide here: ow.ly/Grb850UY5wf
New on the MAPGuide: Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement.
Read the agreement here: ow.ly/k6nS50UY5FW
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: ow.ly/k6nS50UY5FW
Explore the MAPGuide here: lnkd.in/d6ZcxXN
February 20, 2025 at 8:16 PM
New on the MAPGuide: Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement.
Read the agreement here: ow.ly/k6nS50UY5FW
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the agreement here: ow.ly/k6nS50UY5FW
Explore the MAPGuide here: lnkd.in/d6ZcxXN
New on the MAPGuide: This project aims to reduce supply uncertainty and lower the cost of artemisinin for ACTs, particularly in developing countries. Read the agreement here: ghiaa.org/mapguide-hom...
February 11, 2025 at 8:47 PM
New on the MAPGuide: This project aims to reduce supply uncertainty and lower the cost of artemisinin for ACTs, particularly in developing countries. Read the agreement here: ghiaa.org/mapguide-hom...
GHIAA has published comments on the new NIH Intramural Research Program Access Planning Policy: ghiaa.org/mapguide-hom...
January 17, 2025 at 3:11 PM
GHIAA has published comments on the new NIH Intramural Research Program Access Planning Policy: ghiaa.org/mapguide-hom...
Our # 1️⃣ favorite moment of 2024? It has to be welcoming new board members to our team.
The GHIAA team grew with the addition of three new board members in 2024,Paul Felhner, Spring Gombe, and Thi Hanh Cao.
Learn more about our board on our website: ghiaa.org/team/
The GHIAA team grew with the addition of three new board members in 2024,Paul Felhner, Spring Gombe, and Thi Hanh Cao.
Learn more about our board on our website: ghiaa.org/team/
January 8, 2025 at 1:30 PM
Our # 1️⃣ favorite moment of 2024? It has to be welcoming new board members to our team.
The GHIAA team grew with the addition of three new board members in 2024,Paul Felhner, Spring Gombe, and Thi Hanh Cao.
Learn more about our board on our website: ghiaa.org/team/
The GHIAA team grew with the addition of three new board members in 2024,Paul Felhner, Spring Gombe, and Thi Hanh Cao.
Learn more about our board on our website: ghiaa.org/team/
GHIAA's # 2️⃣ favorite moment of 2024? Continuing to grow the GHIAA’s flagship tool, the Master Alliance Provision Guide (MAPGuide)!
In 2024 we added 16 new agreements to the database from the Medicines Patent Pool, Novartis, the Wellcome Trust, the Gates Foundation, and more.
In 2024 we added 16 new agreements to the database from the Medicines Patent Pool, Novartis, the Wellcome Trust, the Gates Foundation, and more.
January 8, 2025 at 1:28 PM
GHIAA's # 2️⃣ favorite moment of 2024? Continuing to grow the GHIAA’s flagship tool, the Master Alliance Provision Guide (MAPGuide)!
In 2024 we added 16 new agreements to the database from the Medicines Patent Pool, Novartis, the Wellcome Trust, the Gates Foundation, and more.
In 2024 we added 16 new agreements to the database from the Medicines Patent Pool, Novartis, the Wellcome Trust, the Gates Foundation, and more.
4️⃣ We participated in the Licensing Executives Society (U.S.A. and Canada), Annual Meeting!
December 17, 2024 at 10:23 PM
4️⃣ We participated in the Licensing Executives Society (U.S.A. and Canada), Annual Meeting!
New on the MAPGuide. Per Gilead’s related press release, the Agreement is part of Gilead’s strategy to facilitate access to its proprietary compound Lenacapavir in 120 primarily low- and lower-middle income countries.
Read the agreement here: ow.ly/vYXI50TU2c0
Read the agreement here: ow.ly/vYXI50TU2c0
December 17, 2024 at 10:21 PM
New on the MAPGuide. Per Gilead’s related press release, the Agreement is part of Gilead’s strategy to facilitate access to its proprietary compound Lenacapavir in 120 primarily low- and lower-middle income countries.
Read the agreement here: ow.ly/vYXI50TU2c0
Read the agreement here: ow.ly/vYXI50TU2c0
This week, we're reflecting on a challenging and fulfilling 2024 by counting down 5 of our favorites moments of the year.
Starting with number 5️⃣, in 2024, we...
Contributed to international vaccinology education with the International Vaccine Institute (IVI).
Starting with number 5️⃣, in 2024, we...
Contributed to international vaccinology education with the International Vaccine Institute (IVI).
December 16, 2024 at 11:56 PM
This week, we're reflecting on a challenging and fulfilling 2024 by counting down 5 of our favorites moments of the year.
Starting with number 5️⃣, in 2024, we...
Contributed to international vaccinology education with the International Vaccine Institute (IVI).
Starting with number 5️⃣, in 2024, we...
Contributed to international vaccinology education with the International Vaccine Institute (IVI).
Novartis grants MPP a freedom-to-operate license to grant non-exclusive sublicences to suitably qualified manufacturers to use certain Patents and a Manufacturing Patent to develop, manufacture and supply pharmaceutical products containing nilotinib.
Read the full agreement here: lnkd.in/ewAXXPY5
Read the full agreement here: lnkd.in/ewAXXPY5
December 15, 2024 at 1:21 AM
Novartis grants MPP a freedom-to-operate license to grant non-exclusive sublicences to suitably qualified manufacturers to use certain Patents and a Manufacturing Patent to develop, manufacture and supply pharmaceutical products containing nilotinib.
Read the full agreement here: lnkd.in/ewAXXPY5
Read the full agreement here: lnkd.in/ewAXXPY5
New on the MAPGuide: Wellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement
Read the full agreement here: lnkd.in/e4mskmiv
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the full agreement here: lnkd.in/e4mskmiv
Explore the MAPGuide here: lnkd.in/d6ZcxXN
December 3, 2024 at 11:53 PM
New on the MAPGuide: Wellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement
Read the full agreement here: lnkd.in/e4mskmiv
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Read the full agreement here: lnkd.in/e4mskmiv
Explore the MAPGuide here: lnkd.in/d6ZcxXN